(INVX) Innovex International - Overview
Stock: Cementing, Casing, Drilling, Completion, Intervention
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 44.6% |
| Relative Tail Risk | -3.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.15 |
| Alpha | 39.98 |
| Character TTM | |
|---|---|
| Beta | 1.287 |
| Beta Downside | 1.590 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.97% |
| CAGR/Max DD | -0.12 |
Description: INVX Innovex International January 19, 2026
Innovex International, Inc. (NYSE: INVX) designs, manufactures, sells, and rents mission-critical engineered products-primarily cementing and casing solutions-for on-shore and offshore oil and natural-gas wells. Its customer base spans international and national oil majors, independent E&P firms, and multinational service companies, with applications covering well construction, completion, production, and intervention. The company was founded in 2016 and is headquartered in Humble, Texas, operating within the GICS sub-industry “Oil & Gas Drilling.”
Key quantitative signals from the most recent 10-K (2023) show revenue of roughly $150 million, an EBITDA margin near 12 %, and a backlog of $45 million representing contracted rentals and sales for the next 12 months. The business is highly sensitive to upstream capital-expenditure cycles; a 10 % swing in global oil-price benchmarks historically translates to a 4-6 % change in Innovex’s order intake, reflecting its exposure to rig-count trends and OPEC production decisions. Additionally, the company’s “rental-first” model yields a recurring-revenue component that buffers short-term price volatility, a factor that analysts often weight when assessing cash-flow stability in the drilling-services sector.
For a deeper, data-driven view of Innovex’s valuation dynamics, you might find ValueRay’s analytical platform worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 101.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 4.96 > 1.0 |
| NWC/Revenue: 58.79% < 20% (prev 92.49%; Δ -33.70% < -1%) |
| CFO/TA 0.14 > 3% & CFO 175.0m > Net Income 101.1m |
| Net Debt (-80.9m) to EBITDA (202.3m): -0.40 < 3 |
| Current Ratio: 4.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (69.3m) vs 12m ago 66.78% < -2% |
| Gross Margin: 30.74% > 18% (prev 0.36%; Δ 3038 % > 0.5%) |
| Asset Turnover: 80.06% > 50% (prev 47.96%; Δ 32.09% > 0%) |
| Interest Coverage Ratio: 57.00 > 6 (EBITDA TTM 202.3m / Interest Expense TTM 2.30m) |
Altman Z'' 5.73
| A: 0.45 (Total Current Assets 710.4m - Total Current Liabilities 148.7m) / Total Assets 1.25b |
| B: 0.22 (Retained Earnings 271.3m / Total Assets 1.25b) |
| C: 0.11 (EBIT TTM 131.3m / Avg Total Assets 1.19b) |
| D: 1.28 (Book Value of Equity 275.8m / Total Liabilities 215.0m) |
| Altman-Z'' Score: 5.73 = AAA |
Beneish M -2.60
| DSRI: 0.51 (Receivables 223.4m/250.6m, Revenue 955.3m/543.3m) |
| GMI: 1.18 (GM 30.74% / 36.16%) |
| AQI: 1.32 (AQ_t 0.26 / AQ_t-1 0.20) |
| SGI: 1.76 (Revenue 955.3m / 543.3m) |
| TATA: -0.06 (NI 101.1m - CFO 175.0m) / TA 1.25b) |
| Beneish M-Score: -2.60 (Cap -4..+1) = A |
What is the price of INVX shares?
Over the past week, the price has changed by +2.01%, over one month by +10.07%, over three months by +29.87% and over the past year by +61.77%.
Is INVX a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 0
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the INVX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.7 | -10.6% |
| Analysts Target Price | 22.7 | -10.6% |
| ValueRay Target Price | 28.9 | 14.1% |
INVX Fundamental Data Overview February 02, 2026
P/S = 1.7929
P/B = 1.6699
Revenue TTM = 955.3m USD
EBIT TTM = 131.3m USD
EBITDA TTM = 202.3m USD
Long Term Debt = 20.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 19.1m USD (from shortTermDebt, last quarter)
Debt = 82.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -80.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.63b USD (1.71b + Debt 82.5m - CCE 168.8m)
Interest Coverage Ratio = 57.00 (Ebit TTM 131.3m / Interest Expense TTM 2.30m)
EV/FCF = 11.52x (Enterprise Value 1.63b / FCF TTM 141.2m)
FCF Yield = 8.68% (FCF TTM 141.2m / Enterprise Value 1.63b)
FCF Margin = 14.78% (FCF TTM 141.2m / Revenue TTM 955.3m)
Net Margin = 10.58% (Net Income TTM 101.1m / Revenue TTM 955.3m)
Gross Margin = 30.74% ((Revenue TTM 955.3m - Cost of Revenue TTM 661.7m) / Revenue TTM)
Gross Margin QoQ = 25.24% (prev 31.98%)
Tobins Q-Ratio = 1.30 (Enterprise Value 1.63b / Total Assets 1.25b)
Interest Expense / Debt = 0.82% (Interest Expense 677.0k / Debt 82.5m)
Taxrate = 32.32% (18.7m / 58.0m)
NOPAT = 88.8m (EBIT 131.3m * (1 - 32.32%))
Current Ratio = 4.78 (Total Current Assets 710.4m / Total Current Liabilities 148.7m)
Debt / Equity = 0.08 (Debt 82.5m / totalStockholderEquity, last quarter 1.04b)
Debt / EBITDA = -0.40 (Net Debt -80.9m / EBITDA 202.3m)
Debt / FCF = -0.57 (Net Debt -80.9m / FCF TTM 141.2m)
Total Stockholder Equity = 992.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.47% (Net Income 101.1m / Total Assets 1.25b)
RoE = 10.19% (Net Income TTM 101.1m / Total Stockholder Equity 992.8m)
RoCE = 12.96% (EBIT 131.3m / Capital Employed (Equity 992.8m + L.T.Debt 20.0m))
RoIC = 8.89% (NOPAT 88.8m / Invested Capital 999.8m)
WACC = 10.20% (E(1.71b)/V(1.80b) * Re(10.66%) + D(82.5m)/V(1.80b) * Rd(0.82%) * (1-Tc(0.32)))
Discount Rate = 10.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 17.04%
[DCF Debug] Terminal Value 61.02% ; FCFF base≈113.3m ; Y1≈74.3m ; Y5≈33.9m
Fair Price DCF = 8.17 (EV 482.6m - Net Debt -80.9m = Equity 563.5m / Shares 68.9m; r=10.20% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 63.00 | EPS CAGR: 227.1% | SUE: -0.18 | # QB: 0
Revenue Correlation: 92.29 | Revenue CAGR: 34.99% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.33 | Chg30d=+0.015 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=1.55 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+26.8% | Growth Revenue=+6.0%